CRO in primary cell models
Preci aims to bridge the gap between animal testing
and the outcome of the clinical trial.
At Preci we collect human-derived cancer tissues
to increase the availability and the diversity of
the cell models, suitable for testing. We are
ready to provide high-quality services for both the early
stages of drug discovery and preclinical development.
Preci develops its screening and molecular profiling
platforms to facilitate your research.